SLA
Click for more information
0.00% $3.34 silk laser australia limited

Company has never stated Ropren antiviral--Rebetron is not...

  1. gunit
    138 Posts.
    clock Created with Sketch.
    12/09/08
    19:24
    Post #: 4261028
    Company has never stated Ropren antiviral--Rebetron is not competition--Ropren will be prescribed in conjunction with Interferon etc. to deal with Hep C-- a huge international problem --What other comparitor do you think could have been used rather than Essentiale or perhaps St. Marys in trials?--re- Bio R's superior efficacy.There just isn't!
    SLA Price at posting: 41.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.